Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS
KRAS mutations have been shown to extend their oncogenic effects beyond the cancer cell, influencing the tumor microenvironment. Herein, we studied the impact of mutant KRAS on the modulation of the pro-tumorigenic properties of cancer-associated fibroblasts (CAFs), including α-SMA expression, TGFβ1...
Main Authors: | Patrícia Dias Carvalho, Susana Mendonça, Flávia Martins, Maria José Oliveira, Sérgia Velho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/16/2490 |
Similar Items
-
Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors
by: Patrícia Dias Carvalho, et al.
Published: (2022-06-01) -
Oncogenic KRAS: Signaling and Drug Resistance
by: Hyeon Jin Kim, et al.
Published: (2021-11-01) -
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
by: Fernand Bteich, et al.
Published: (2023-07-01) -
The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali
by: Ayu Dewi Ni Nyoman, et al.
Published: (2022-03-01) -
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01)